Doğan Akif, Aydıner Ömer
Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Sancaktepe, Turkey.
Dr. Lütfi Kırdar City Hospital, Kartal, Turkey.
Pol J Radiol. 2024 Dec 10;89:e561-e565. doi: 10.5114/pjr/194651. eCollection 2024.
Recurrent malignant ascites is a common and challenging condition in cancer patients, often lacking a standardized treatment protocol. Small-scale studies in the literature have been insufficient to establish a treatment standard. The aim of our study was to investigate the effectiveness and safety of pigtail peritoneal catheter application in the treatment of malignant ascites.
We conducted a retrospective analysis of patients who had pigtail catheters inserted between January 2017 and December 2022. The study focused on the success rate of the procedure, catheter dwell time, complication rates, and the factors influencing these outcomes.
A total of 196 patients, 102 of whom were female, with malignant ascites were included in the study. The median age was 65.5 years. The procedure had a 100% success rate, with no procedure-related deaths or major complications. The overall minor complication rate, including bleeding, minor cellulitis, leakage, and blockage, was 52%. Patients with comorbidities experienced statistically significantly more complications ( < 0.05). The median catheter dwell time was 31 days (range: 3-181 days).
Pigtail peritoneal catheters provide effective and safe minimally invasive fluid drainage for the treatment of malignant ascites. The most critical factors for preventing procedure-related complications and ensuring procedural success include proper indication, correct timing, procedural expertise, and the involvement of well-trained patients and caregivers.
复发性恶性腹水是癌症患者常见且具有挑战性的病症，通常缺乏标准化的治疗方案。文献中的小规模研究不足以确立治疗标准。我们研究的目的是探讨猪尾状腹膜导管应用于治疗恶性腹水的有效性和安全性。
我们对2017年1月至2022年12月期间插入猪尾状导管的患者进行了回顾性分析。该研究聚焦于手术成功率、导管留置时间、并发症发生率以及影响这些结果的因素。
本研究共纳入196例恶性腹水患者，其中女性102例。中位年龄为65.5岁。该手术成功率为100%，无手术相关死亡或严重并发症。包括出血、轻度蜂窝织炎、渗漏和堵塞在内的总体轻微并发症发生率为52%。合并症患者的并发症在统计学上显著更多（<0.05）。导管中位留置时间为31天（范围：3 - 181天）。
猪尾状腹膜导管为恶性腹水的治疗提供了有效且安全的微创液体引流。预防手术相关并发症和确保手术成功的最关键因素包括恰当的适应症、正确的时机、手术专业知识以及训练有素的患者和护理人员的参与。
